UK Myasthenia Gravis Market: Advancing Treatment for a Rare...

agregó una foto Saúde & Bem Estar

2026-10-01 04:58:34 -

UK Myasthenia Gravis Market: Advancing Treatment for a Rare Neuromuscular Disorder

The UK Myasthenia Gravis Market was valued at USD 62.78 million in 2024 and is projected to grow to USD 143.58 million by 2035, registering a CAGR of 7.81% during the forecast period. This significant growth trajectory reflects the essential role of myasthenia gravis treatments in addressing the demand for effective management of this rare autoimmune disorder, improved patient outcomes, and...

0 Commentarios 0 Acciones 0 Vista previa